Depression and anxiety in COPD


Depression and anxiety in COPD are regular in patients with chronic obstructive pulmonary disease (COPD), assessments of their pervasiveness differ significantly. These likely reflect the assortment of scales and strategies used to measure such symptoms. Patients with COPD with three or more comorbidities are more likely to be frequently hospitalized and may die prematurely compared to COPD patients without comorbidities.  An uplifted experience of dyspnoea is probably contributing component to anxiety. Feelings of depression may be precipitated by the loss and grief associated with the disability of COPD. Smoking has been associated with nicotine addiction, and the factors that contribute to smoking may also predispose to anxiety and depressive disorders. The cause of depression and anxiety symptoms are multifactorial and include behavioural, social and biological factorsLung Conferences exhibits randomized controlled trials show that activity exercise training and precisely chose pharmacological treatment are regularly effective in ameliorating anxiety and depression.


  • Prevalence in COPD
  • Classification and diagnostic criteria
  • Clinical features and impact
  • Screening and diagnosis
  • Risk factors
  • Mechanism of potential association with COPD

Related Conference of Depression and anxiety in COPD

November 22-23, 2021

11th International Conference on COPD and Lungs

Singapore City, Singapore
November 29-29, 2021

2nd International Conference on Lung Diseases

London, UK
March 21-22, 2022

42nd World Conference on Lung Diseases & Pulmonology

Brussels, Belgium

Depression and anxiety in COPD Conference Speakers

Recommended Sessions

Related Journals

Are you interested in